March 2016

Volume 28 Issue 3
We report a case of minimal acute recoil detected by optical frequency-domain imaging (OFDI) following bioresorbable scaffold (BRS) implantation for the treatment of a fibrocalcific lesion. 
We demonstrate the safety and clinical efficacy of ultrasound-accelerated thrombolysis therapy with the EkoSonic Endovascular System infusion catheter system and highlight its use in resolving intracardiac thrombi and impeding the propagation of pulm…
Coronary artery perforation (CAP) is a rare but serious complication of percutaneous coronary intervention. We review the risk factors, common causes, complications, and treatment options for CAP. 
While the role of mitral repair for degenerative mitral regurgitation is clear, we continue to struggle with whether treating FMR in the setting of LV dysfunction is ultimately beneficial.
The Mynx device (Access Closure, Inc), a novel extravascular closure device, uses a water-soluble non-thrombogenic polyethylene glycol plug. We report retrospective analysis of success, complication rates, and associated factors in 432 consecutive pa…
This study aimed to compare the effectiveness of alcohol septal ablation in patients with vs without extreme septal hypertrophy.   
Using near-infrared light technology, OCT today offers excellent in vivo intravascular imaging of the vessel wall, but it is unclear whether further stent optimization may allow faster neointimal coverage or alter positive remodeling, which may resul…
Post-PCI optical coherence tomography may be a clinically useful tool in angiographically optimized stenting. Prospective studies will provide further clarity on the place of OCT in this setting. 
Can favorable outcomes for CTO-PCI be achieved at less experienced centers? Bridging the gap in success between experienced and less experienced centers and improving efficiency remain top priorities in 2016. 
The aim of this first-in-human (FIH) study was to evaluate the efficacy and safety of the novel NovaCross microcatheter system in eligible consecutive patients with chronic total occlusion (CTO).